These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35320951)

  • 1. Vimentin Protein In Situ Expression Predicts Less Tumor Metastasis and Overall Better Survival of Endometrial Carcinoma.
    Zhang X; Cao G; Diao X; Bai W; Zhang Y; Wang S
    Dis Markers; 2022; 2022():5240046. PubMed ID: 35320951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
    Zhang Q; Xia T; Qi C; Du J; Ye C
    BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rictor is an independent prognostic factor for endometrial carcinoma.
    Wen SY; Li CH; Zhang YL; Bian YH; Ma L; Ge QL; Teng YC; Zhang ZG
    Int J Clin Exp Pathol; 2014; 7(5):2068-78. PubMed ID: 24966915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of lymphovascular space invasion in endometrial cancer using the 55-gene signature selected by DNA microarray analysis.
    Watanabe T; Honma R; Kojima M; Nomura S; Furukawa S; Soeda S; Watanabe S; Fujimori K
    PLoS One; 2019; 14(9):e0223178. PubMed ID: 31557240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis.
    Shang P; Meng F; Liu Y; Chen X
    Tumour Biol; 2015 Jun; 36(6):4479-85. PubMed ID: 25934333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics.
    Qiu X; Gao Z; Shao J; Li H
    Ann Hum Genet; 2020 Nov; 84(6):437-446. PubMed ID: 32628282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a nine-gene prognostic model for predicting overall survival of patients with endometrial carcinoma.
    Ying J; Wang Q; Xu T; Lyu J
    Cancer Med; 2018 Jun; 7(6):2601-2611. PubMed ID: 29665298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell.
    Lu L; Shen Y; Tseng KF; Liu W; Duan H; Meng W
    Cancer Biomark; 2016 Jun; 17(2):171-7. PubMed ID: 27540975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of 16α-
    Yamada S; Tsuyoshi H; Yamamoto M; Tsujikawa T; Kiyono Y; Okazawa H; Yoshida Y
    J Nucl Med; 2021 May; 62(5):636-642. PubMed ID: 33008930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival.
    Mauland KK; Wik E; Hoivik EA; Kusonmano K; Halle MK; Berg A; Haugland HK; Øyan AM; Kalland KH; Stefansson IM; Akslen LA; Krakstad C; Trovik J; Werner HM; Salvesen HB
    Oncotarget; 2017 Feb; 8(6):9696-9707. PubMed ID: 28039471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
    Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
    Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CKMT1A is a novel potential prognostic biomarker in patients with endometrial cancer.
    Wang Y; Zhao S; Qin Q; Gao X; Zhang X; Zhang M; Jiang Y; Ji X; Zhu H; Zhao X; Li H
    PLoS One; 2022; 17(1):e0262000. PubMed ID: 35077462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its clinical significance.
    Hu Y; Yu L; Xia F; Liang F; Cheng C; Huang Y; Xiao L
    Clin Transl Oncol; 2021 Aug; 23(8):1711-1716. PubMed ID: 33635467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
    Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
    Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
    Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
    Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of MMSET in endometrial cancer: a clinicopathologic study.
    Xiao M; Yang S; Chen J; Ning X; Guo L; Huang K; Sui L
    J Surg Oncol; 2013 Mar; 107(4):428-32. PubMed ID: 22886632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of LncRNA FER1L4 in endometrial carcinoma is associated with favorable survival outcome.
    Kong Y; Ren Z
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8113-8118. PubMed ID: 30556848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.